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The expression of the replication-dependent histone mRNAs is tightly regulated during the cell cycle. As cells
progress from G1 to S phase, histone mRNA levels increase 35-fold, and they decrease again during G2 phase.
Replication-dependent histone mRNAs are the only metazoan mRNAs that lack polyadenylated tails, ending
instead in a conserved stem-loop. Much of the cell cycle regulation is posttranscriptional and is mediated by
the 3* stem-loop. A 31-kDa stem-loop binding protein (SLBP) binds the 3* end of histone mRNA. The SLBP
is necessary for pre-mRNA processing and accompanies the histone mRNA to the cytoplasm, where it is a
component of the histone messenger RNP. We used synchronous CHO cells selected by mitotic shakeoff and
HeLa cells synchronized at the G1/S or the M/G1 boundary to study the regulation of SLBP during the cell
cycle. In each system the amount of SLBP is regulated during the cell cycle, increasing 10- to 20-fold in the late
G1 and then decreasing in the S/G2 border. SLBP mRNA levels are constant during the cell cycle. SLBP is
regulated at the level of translation as cells progress from G1 to S phase, and the protein is rapidly degraded
as they progress into G2. Regulation of SLBP may account for the posttranscriptional component of the cell
cycle regulation of histone mRNA.
The replication-dependent histone mRNAs are tightly reg-
ulated during the cell cycle, increasing 35-fold as cells progress
from G1 to S phase (18). There is only a three- to five-fold
increase in the rate of transcription of the histone genes (7,
19), indicating that much of the regulation is posttranscrip-
tional. The posttranscriptional component of cell cycle regula-
tion is mediated by the 39 end of the histone mRNA (32, 35),
which is a highly conserved stem-loop (34). The only process-
ing step necessary for formation of the mature histone mRNA
is an endonucleolytic cleavage to form the 39 end (14). Cleav-
age is directed by two cis-acting elements, the stem-loop which
binds to the hairpin binding factor (37, 38), and a purine-rich
sequence about 10 nucleotides (nt) 39 of the cleavage site that
binds the 59 end of U7 snRNA (3, 39, 55). Hairpin binding
factor is composed of a single 31-kDa protein, the stem-loop
binding protein (SLBP) (10, 60) or hairpin binding protein
(33), which is required for processing in vivo (44) and which
remains with the mature mRNA as a component of the cyto-
plasmic messenger RNP (mRNP) (9, 17). At least one addi-
tional factor, a heat-labile factor, is required for processing,
but this factor has not been well defined biochemically (15).
Two posttranscriptional regulatory steps contribute to the
cell cycle regulation of histone mRNA concentrations. Pro-
cessing is regulated as cells progress from G1 to S phase, and
the half-life of histone mRNA is reduced to about 10 min at
the end of S phase (18), resulting in the destruction of histone
mRNA prior to mitosis. We (60) and others (33) recently
cloned the cDNA for the SLBP from several species using the
yeast three-hybrid system (50). Here we show that SLBP, a
major trans-acting factor necessary for histone pre-mRNA pro-
cessing, is regulated during the cell cycle by both posttranscrip-
tional and posttranslational processes. Regulation of SLBP is
likely a critical component of the cell cycle regulation of his-
tone mRNA.
MATERIALS AND METHODS
Cell culture and synchronization. CHO cells were grown in McCoy’s 5A
medium with 10% calf serum and Pen-Strep as previously described (18). To
select synchronous cells, an automated shakeoff device capable of simultaneously
shaking 12 T75 flasks was constructed (11). Mitotic cells were collected by
shaking every 10 min and stored at 4°C. Cells collected over a 4-h period were
pooled and plated (0.5 3 106 to 1 3 106 cells per 10-mm plate). The number of
cells in S phase was assessed by labeling cells with 59-bromo-29-deoxyuridine
(BrdU) using the In Situ Cell Proliferation Kit (Boehringer Mannheim, India-
napolis, Ind.). Nuclei that had incorporated BrdU into DNA during the labeling
period were visualized by staining with FastRed (Boehringer Mannheim).
To obtain populations of cells in G2 phase, HeLa cells were arrested by double
thymidine block. Cells were blocked for 18 h with 2 mM thymidine, released for
9 h by washing out the thymidine, and then blocked again with 2 mM thymidine
for 17 h to arrest all the cells at the beginning of S phase. The cells were released
by washing out the thymidine, and lysates were prepared each hour after release
from thymidine. The cells progressed through G2 and mitosis synchronously.
HeLa cells were also synchronized by arresting them at the G1-S border with 2
mM thymidine for 18 h, followed by a 3-h release, and then arrested at mitosis
with 100 ng of nocodazole per ml for 12 h. The cells were released from the
nocodazole block with two washes of fresh medium and allowed to progress
through G1 and into S phase. Any cells that had not attached 6 h after release
from nocodazole were discarded. The cell cycle position of the cells was deter-
mined by propidium iodide staining and flow cytometry at the University of
North Carolina Flow Cytometry facility.
Preparation of cell lysates and detection of SLBP and cyclin proteins. CHO
cells were collected, washed once in phosphate-buffered saline (PBS), and lysed
by incubation for 10 min in NP-40 lysis buffer (50 mM Tris [pH 7.5], 150 mM
NaCl, 0.5% NP-40, 1 mM dithiothreitol). The insoluble material was pelleted by
centrifugation at 16,000 3 g in a microcentrifuge. The HeLa cells were lysed the
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same way or in some experiments were lysed in 1% sodium dodecyl sulfate (SDS)
and boiled for 5 min. Western blots were performed by standard protocols (60).
Typically, 25 mg of total cell protein was resolved on an SDS–10% polyacryl-
amide gel and transferred to nitrocellulose. SLBP was detected with antibodies
raised to the C terminus of the mouse SLBP (60). Mobility shift assays were
performed with whole-cell lysates as previously described (36, 43). Antibodies to
human cyclin A and cyclin B raised against glutathione-S-transferase fusion
proteins were a gift from Yue Xiong (61).
Preparation of RNA and analysis of histone mRNA and SLBP mRNA. Total
cell RNA was prepared with the Ultraspec RNA isolation system (Biotecx Lab-
oratories, Inc., Houston, Tex.). Concentrations of several mRNAs were deter-
mined by Northern blotting. Briefly, 10 mg of total RNA was denatured in 50%
formamide plus 2.2 M formaldehyde, resolved on a 1% agarose–formaldehyde
gel, transferred to a nylon membrane (Hybond; Amersham Pharmacia Biotech,
Piscataway, N.J.) via capillary action, and cross-linked using a Stratalinker (Strat-
agene, La Jolla, Calif.). The blots were probed with either the mouse SLBP
cDNA (NcoI-SpeI fragment), the rat glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) cDNA, or the mouse histone H3.2-614 gene. The appropriate restric-
tion fragments were purified by agarose gel electrophoresis and labeled by
random priming in the presence of [a-32P]dCTP. Blots were hybridized in
Quikhyb (Stratagene) for 4 h at 55°C. U7 snRNA Northern blots were performed
on total RNA resolved by electrophoresis on a 10% polyacrylamide–7 M urea gel
using a riboprobe complementary to the mouse U7 snRNA (10). Where indi-
cated, the hamster histone H3 mRNA was mapped in an S1 nuclease assay with
the mouse H3.2-614 gene, labeled at the SalI site (16, 18).
Labeling of cells and analysis of SLBP synthesis rate. CHO cells were labeled
in Dulbecco’s modified Eagle’s medium (DMEM) without methionine and cys-
teine (ICN Pharmaceuticals, Costa Mesa, Calif.) supplemented with 10% dia-
lyzed fetal bovine serum (Gibco-BRL, Gaithersburg, Md.) (24). For each point,
a separate dish (25 mm) containing 106 cells was used. Cells were preincubated
in DMEM without methionine and cysteine for 1 h prior to labeling to deplete
the intracellular stores of methionine and cysteine. The cells were labeled with 1
mCi of [35S]methionine-cysteine (NEN Life Science Products, Boston, Mass.) in
2 ml of medium for 15 min. The label was removed, and the cells were washed
in 13 PBS and lysed in NP-40 lysis buffer. Equal numbers of trichloroacetic
acid-A precipitable counts (5 3 106 cpm) were used for each immunoprecipita-
tion. Lysates were precleared with protein A-agarose beads and then incubated
with affinity-purified anti-SLBP for 1 h. The SLBP-antibody complex was recov-
ered by binding to protein A-agarose beads, and the beads were washed exten-
sively with NP-40 lysis buffer. SLBP was eluted by heating the samples in SDS
loading buffer and resolved by gel electrophoresis. The amount of labeled SLBP
was quantified with a PhosphorImager (Molecular Dynamics, Sunnyvale, Calif.).
Analysis of distribution of mRNAs in polyribosomes. HeLa cells were syn-
chronized as described above, and polyribosomes were analyzed by a modifica-
tion of published methods (5, 25). Just prior to harvesting, the cells were treated
with cycloheximide (0.1 mM) to freeze the mRNAs on polyribosomes. The cells
were washed in PBS and then lysed by gentle shaking in 0.5% NP-40–0.1 M
NaCl–10 mM MgCl2–2 mM dithiothreitol–50 mM Tris-HCl (pH 7.5) containing
200 U of RNasin, 100 mg of cycloheximide, 200 mg of heparan, and 10 ml of
protease inhibitor cocktail (catalog no. P-8340; Sigma Chemical, St. Louis, Mo.)
per ml. The nuclei and membranes were removed by centrifugation at 10,000 3
g for 10 min. The lysates were layered on 9-ml 15 to 40% (wt/vol) sucrose
gradients in 0.15 M NaCl–5 mM MgCl2–25 mM Tris-HCl (pH 7.5) and centri-
fuged for 140 min at 35,000 rpm in an SW41 rotor. The gradients were fraction-
ated with a Densiflow apparatus (Buchler Instruments, Lawrence, Kans.), and
0.6-ml fractions were collected. RNA was prepared from each fraction using
TRIzol (Gibco-BRL). The RNA was resolved by agarose gel electrophoresis and
detected by staining with ethidium bromide. A second aliquot of RNA from each
fraction was treated with formaldehyde, resolved by agarose gel electrophoresis,
transferred to nitrocellulose, and analyzed for SLBP and GAPDH mRNA as
described above.
Chemicals. Hydroxyurea and N-acetyl-leucyl-leucyl-methioninal (LLM) were
obtained from Sigma. Aphidicolin and carbobenzoxy-L-leucyl-L-leucyl-L-leucinal
(Mg132) were obtained from Calbiochem.
RESULTS
Histone mRNAs are tightly regulated during the cell cycle at
multiple steps. Much of the regulation is due to the 39 end of
histone mRNA (18, 56). The protein which binds the 39 end of
histone mRNA, SLBP, participates in many steps of histone
mRNA metabolism in both the nucleus (9) and the cytoplasm
(17). Since SLBP is the only factor that interacts with the 39
end of histone mRNA, it is a possible regulator of histone
mRNA during the cell cycle. In the nucleus, SLBP is present as
a free protein, which can be detected both by mobility shift
assays and by Western blotting (43). SLBP is also present in
the cytoplasm on the polyribosomes associated with histone
mRNA (9, 17). In contrast to the nuclear SLBP, the cytoplas-
mic SLBP that is stably bound to histone mRNA cannot be
detected by mobility shift assay (17) but can be detected by
Western blotting.
To understand the relationship between cell cycle progres-
sion and histone mRNA regulation, it is important to study
continuously cycling cells. Most studies of cell cycle regulation
have utilized cells arrested at different points of the cell cycle,
either using “natural” conditions, such as serum starvation, or
drugs which arrest cells at various points in the cell cycle. For
example, studying the release of serum-starved cells from G0
by stimulation with serum results in analysis of a resting-to-
growing transition as well as cell cycle progression.
SLBP is a cell cycle-regulated protein. Few studies have
analyzed cell cycle regulation in a system where one can obtain
continuously cycling cells. Analysis of CHO cells selected by
mitotic shakeoff allows the study of a highly synchronous pop-
ulation of cells whose growth has been minimally perturbed.
To obtain enough cells for biochemical measurements, we con-
structed an automated shakeoff apparatus that allows us to
collect 107 mitotic cells in 4 h (11). Mitotic cells are collected
every 10 min and can be stored for up to 4 h at 4°C (18, 47).
Cells are in metaphase when selected and progress into G1
phase within 30 min after plating. Between 80 and 95% of the
cells plated entered S phase, as determined by labeling with
BrdU. The cells started to enter S phase after 3 to 5 h, de-
pending on the experiment.
We analyzed the levels of SLBP during G1 and S phase by
Western blot with an antibody that we prepared against a
synthetic 13-amino-acid peptide corresponding to the C termi-
nus of SLBP (60). No SLBP was detected in mitotic cells by
Western blotting, and small amounts were detected in G1 cells
1 or 2 h after plating (Fig. 1A, lanes 1 to 3). As cells entered S
phase (3.5 to 5 h), SLBP levels increased approximately 15- to
20-fold and remained constant throughout S phase (Fig. 1A,
lanes 4 to 6). As a control, we measured the levels of the
mitotic cyclins A and B by Western blotting of the same ex-
tracts (Fig. 1A). Cyclins A and B are present in mitotic extracts
(which are from metaphase cells) but are rapidly degraded as
cells complete mitosis. The levels of histone H3 mRNA in the
same experiment were measured by S1 nuclease mapping. As
reported previously (18), the increase in histone mRNA levels
closely parallels the entry of cells into S phase (Fig. 1B). In
contrast, the levels of U7 snRNA, another component of the
histone pre-mRNA processing machinery (39, 55), were con-
stant as cells progressed from G1 to S phase (Fig. 1B). Note
that SLBP levels were maximal by 3.5 h, when less than 20% of
the cells had entered S phase, and that SLBP levels peaked
before histone mRNA levels peaked (Fig. 1A and B, lanes 4
and 5).
We also measured the amount of free SLBP, active in RNA
binding, at different times during the cell cycle by a mobility
shift assay with the histone stem-loop as a probe (43). We used
whole-cell lysates in these experiments. All the RNA binding
activity which formed a complex with the stem-loop was due to
SLBP, since the complex was completely shifted by the anti-
body to the C-terminal peptide (Fig. 1C, lanes 2 and 3). Little
SLBP binding activity was detected in mitotic cells or 1 h after
mitosis (Fig. 1C, lanes 4 and 5), but the activity increased
dramatically as cells entered S phase (Fig. 1C, lane 6). SLBP
activity peaked at 3.5 h after mitosis, prior to the entry of most
of the cells into S phase and before the maximum accumula-
tion of histone mRNA (Fig. 1C, lane 6). The activity decreased
threefold by 8 h, when 85 to 90% of the cells were in S phase
(Fig. 1C, lane 7) and histone mRNA levels were maximal. The
decrease in SLBP activity between 3.5 and 8 h probably reflects
the accumulation of SLBP bound to histone mRNA, effectively
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reducing the amount of free SLBP available for binding the
probe (17).
SLBP mRNA levels are constant during the cell cycle.
Mouse and human SLBP mRNAs are each about 1,730 nt, not
including the poly(A) tail (60). We used the mouse SLBP
cDNA as a probe to detect the hamster SLBP mRNA on a
Northern blot. The mouse SLBP cDNA recognizes a 1.9-kb
transcript in total hamster RNA by Northern blotting (Fig. 2),
in good agreement with the expected size of SLBP mRNA.
Since the transcript comigrates with 18S rRNA, total hamster
RNA was fractionated into polyadenylated [poly(A)1] and
poly(A)2 fractions on oligo(dT)-cellulose (Fig. 2A). The great
majority of the 1.9-kb transcript was detected in the poly(A)1
fraction (Fig. 2A, lanes 4 to 6) and comigrated with the mouse
SLBP mRNA (Fig. 2A, lane 7), demonstrating that we were
detecting the hamster SLBP mRNA with the mouse probe.
Little cross-hybridization was observed to 10 and 20 mg of
hamster poly(A)2 RNA with the mouse SLBP probe (Fig. 2A,
lanes 2 and 3). All of the histone H3 mRNA was in the
poly(A)2 fraction (Fig. 2A, lanes 2 and 3), and the GAPDH
mRNA was in the poly(A)1 fraction.
We analyzed the levels of SLBP mRNA using total-cell
RNA from CHO cells at different times after mitotic selection
(Fig. 2B). Two independent experiments are shown. The levels
of SLBP mRNA did not change significantly as cells pro-
gressed from mitosis to S phase (Fig. 2B, top panel, lanes 2 to
6 and lanes 7 to 9). SLBP mRNA was present in mitotic cells
FIG. 1. SLBP is cell cycle regulated. CHO cells were selected by mitotic
shakeoff, and whole-cell extracts or total RNA was prepared at the times (hours)
indicated above each lane. All panels used extracts and RNA from the same
experiment. (A) Cells were harvested in mitosis (0 h), G1 phase (1 and 2 h), or
S phase (3.5 to 8 h). SLBP (top), cyclin A (middle), and cyclin B (lower) levels
were determined by Western blotting with extracts prepared at the indicated
times. The percentage of cells in S phase at each time is shown above each lane.
(B) Five micrograms of total RNA, prepared either from asynchronous cells (A)
or from cells plated for the number of hours indicated above each lane, was
analyzed for histone mRNA and U7 snRNA. Hamster histone H3 mRNA was
measured with a 39-end S1 nuclease assay with the mouse H3.2-614 gene, labeled
at the SalI site, which maps all the hamster H3 histone mRNAs from codon 58
to the stop codon (18). The levels of U7 snRNA were determined by Northern
blot analysis with a riboprobe complementary to the mouse U7 snRNA (10). In
other experiments, the levels of U7 and histone mRNA in the mitotic cells (0 h)
were similar to those at the 1-h time point. (C) The activity of SLBP in total-cell
extracts was determined by mobility shift assay with the histone stem-loop as a
probe (P). SLBP present in asynchronous cells (A) forms a specific complex
which can be supershifted (ss) with antibodies to the C terminus of the SLBP
(lanes 2 and 3). The activity of the SLBP was determined in cells plated for the
times (hours) indicated above each lane. The SLBP:RNA complex is indicated by
an arrow. The band migrating slightly above the probe is probably a dimer of the
probe. There was not enough 5-h extract to analyze in this experiment, but in
other experiments the 5-h and 8-h extracts showed similar activity.
FIG. 2. SLBP mRNA is constant during the cell cycle. (A) Total RNA from
exponentially growing CHO cells was fractionated into poly(A)2 and poly(A)1
RNA by chromatography on oligo(dT)-cellulose. A 10-mg amount of total RNA
(lane 1), 10 or 20 mg of poly(A)2 RNA (lanes 2 and 3), and the equivalent
amount of poly(A)1 RNA from 10, 20, or 50 mg of total cell RNA (lanes 4 to 6)
was resolved by gel electrophoresis, transferred to a nylon membrane, and
hybridized with the mouse SLBP cDNA (top), rat GAPDH cDNA (middle), or
mouse histone H3-614 gene (bottom). Lane 7 is 10 mg of RNA from mouse
myeloma cells. (B) Total-cell RNA was prepared from cells selected by mitotic
shakeoff at the indicated times (hours) after plating (lanes 2 to 9). Two inde-
pendent experiments are shown (lanes 2 to 6 and 7 to 9). Over 80% of these cells
entered S phase by 8 h in the first experiment, and 95% of the cells entered S
phase in the second experiment, as judged by BrdU labeling. A 10-mg amount of
RNA was separated by agarose gel electrophoresis and analyzed as in panel A
(lanes 2 to 9). Lane 1 is poly(A)1 RNA from the equivalent of 20 mg of total
RNA from asynchronous cells.
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and remained constant into late S phase (10 h after mitosis)
(Fig. 2B, lane 9). The blot was stripped and reprobed with the
rat GAPDH gene as a loading control (Fig. 2B, middle panel).
As a control for S-phase entry, the same blot was reprobed
with the mouse histone H3 gene (Fig. 2B, lower panel). Since
SLBP protein levels change 10- to 20-fold while SLBP mRNA
levels are constant, the major regulation of SLBP must be at
the translational or posttranslational level.
Regulation of SLBP during the G1-to-S-phase transition.
The low levels of SLBP in G1 cells could be due to synthesis
and rapid degradation of the SLBP during G1 or to a failure to
translate SLBP mRNA. The mitotic cyclins, for example, con-
tinue to be synthesized and rapidly degraded during G1 in both
mammalian cells (4) and yeast cells (46). To determine wheth-
er the SLBP is rapidly degraded by the proteasome in G1, we
treated G1 cells with the proteasome inhibitor Mg132 for 1 h.
The levels of SLBP were unaffected by treatment of G1 cells
with Mg132 (Fig. 3A, lanes 1 to 4), although cyclin A protein
levels increased three- to fivefold (Fig. 3A, lane 7). An inactive
analogue of the inhibitor, LLM, had no effect on either SLBP
or cyclin A levels. Thus, rapid turnover of SLBP by the pro-
teasome is not responsible for the low levels of SLBP in G1.
We cannot rule out that a mechanism other than the protea-
some could be responsible for rapidly degrading SLBP in G1.
A second possibility is that the translation rate of the SLBP
is regulated. We analyzed the in vivo translation rate of SLBP
mRNA by pulse labeling cells for 15 min with [35S]methionine
and then immunoprecipitating the labeled proteins with anti-
SLBP. Equal amounts of radioactive protein were assayed
from each time point. Since translation of most mRNAs is
inhibited during mitosis, the overall rate of methionine incor-
poration increased fourfold during the first 2 h after mitosis,
but after 2 h the rate of overall protein synthesis had reached
a constant level (not shown). In the labeling experiments, cells
started to enter S phase only after 4 to 5 h, which is later than
in other experiments, as a result of the depletion of methio-
nine. G1 cells did not synthesize significant amounts of SLBP
during the short pulse, while cells entering S phase or in S
phase synthesized SLBP at a significantly higher rate (Fig. 3B).
This result was observed in three independent experiments,
and there was a three- to sixfold increase in labeling in each
experiment. There is little change in SLBP mRNA levels dur-
ing this time (Fig. 2B). We conclude that the SLBP is not
rapidly degraded in G1 but that its translation rate is regulated
between G1 and S phase. Since equal numbers of counts were
loaded from each time point, the four- to fivefold increase in
overall translation coupled with the three- to sixfold increase in
selective translation of SLBP accounts for the 15- to 20-fold
increase in SLBP protein levels observed as the CHO cells
progress from mitosis through G1 into S phase. Further evi-
dence for translation regulation is provided by analysis of poly-
ribosomes in HeLa cells, shown below (see Fig. 9). We were
not able to obtain enough cells by mitotic shakeoff to carry out
the polyribosome analysis.
SLBP accumulates in late G1 phase. To assess whether the
increase in SLBP levels required ongoing DNA replication, we
arrested the cells collected by mitotic shakeoff at the G1/S
border by treatment with inhibitors of DNA synthesis. One
hour after plating, when all the cells were still in G1, they were
treated for 4 h with either aphidicolin, which blocks DNA
polymerase a, or hydroxyurea, which inhibits ribonucleotide
reductase. Most of the untreated control cells have entered S
phase by this time (5 h after mitosis). In contrast, ,1% of the
cells treated with the inhibitors were synthesizing DNA 5 h
after mitosis, as assayed by BrdU labeling.
The levels of SLBP protein and histone H3 mRNA were
measured in these cells (Fig. 4A). SLBP has increased to con-
trol levels, although no histone mRNA has accumulated (Fig.
4A, lanes 1 and 3). When the inhibitor was removed, .80% of
the cells entered S phase within 2 h. The levels of SLBP re-
mained relatively constant, while histone mRNA accumulated
rapidly (Fig. 4A, lanes 2 and 4).
FIG. 3. Translational control of SLBP during G1 phase. (A) Cells were se-
lected by mitotic shakeoff. One hour after selection, cells were left untreated (2
hr. G1, lanes 1 and 5) or treated with either dimethyl sulfoxide (DMSO, lanes 2
and 6), 50 mM Mg132 in DMSO (lanes 3 and 7), or 50 mM LLM in DMSO (lanes
4 and 8). Lysates were prepared 1 h after treatment, and the amount of SLBP was
determined by Western blotting (lanes 1 to 4). The same lysates were blotted for
cyclin A (lanes 5 to 8). (B) Mitotic cells were selected and plated. At the
indicated times after plating, cells were labeled with [35S]methionine for 15 min.
The lysates, containing 5 3 106 cpm of labeled protein, were precipitated with
affinity-purified anti-SLBP, and the precipitated proteins were analyzed by gel
electrophoresis. The results of two experiments are shown. In lane C, the anti-
genic peptide was incubated with the antibody prior to precipitation of a sample
labeled at 8 h after plating. The position of SLBP is indicated by the arrow.
FIG. 4. SLBP accumulates independently of histone mRNA. (A) SLBP ac-
cumulates prior to the G1/S boundary. Mitotic cells were plated, and 1 h after
plating they were treated with either aphidicolin (5 mg/ml) or hydroxyurea (5
mM) for 4 h to arrest cells at the G1/S boundary (lanes 1 and 3, B for blocked
cells). The cells were then washed and incubated for 2 h in normal medium to
allow them to enter S phase (lanes 2 and 4, R for released). As a control, cells
were left untreated and harvested in parallel at 5 or 7 h after mitosis (lanes 5 and
6). Lysates and total-cell RNA were prepared from all cells. The levels of SLBP
were measured by Western blotting (top), and the levels of histone H3 mRNA
were measured by S1 nuclease protection analysis (middle). As a control for
RNA recovery, the levels of U1b RNA were determined by an RNase protection
assay (18) (bottom). (B) The SLBP RNA-binding activity in total-cell lysates was
determined by mobility shift assay using the 26-nt histone stem-loop probe (P).
Lysates were prepared from synchronous cell populations at the indicated times
(hours) after mitosis (lanes 1 to 3), cells blocked at the G1/S boundary with
aphidicolin (lane 4), or blocked cells 2 h after removal of the drug (lane 5). The
SLBP-RNA complex is indicated by an arrow.
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The amount of SLBP binding activity, measured by mobility
shift assay, also increased between 1 and 5 h after plating, when
cells have entered S phase (Fig. 4B, lanes 1 to 3). The binding
activity was not affected by blocking cells at the G1/S border
with aphidicolin (Fig. 4B, lane 4) or when cells were released
from the block (Fig. 4B, lane 5). Identical results were ob-
tained with lysates from cells treated with hydroxyurea (data
not shown). Thus, accumulation of SLBP does not require
DNA replication but is probably a result of a cell cycle signal
that occurs prior to entry into S phase.
Half-life of SLBP in CHO cells. To assess the half-life of
SLBP in CHO cells, we pulse-labeled both asynchronous cells
and S-phase cells (5 h after plating) with [35S]methionine for
20 min, the label was washed out, and the cells were chased in
medium containing excess unlabeled methionine for various
amounts of time. The amount of labeled SLBP was determined
by antibody precipitation followed by gel electrophoresis, as in
Fig. 3. SLBP has a half-life of about 2 h in either asynchronous
or S-phase cells (Fig. 5). Since there is at least a 10- to 20-fold
decrease in SLBP levels in the 2 h between the end of S phase
and entry into mitosis, the half-life of SLBP must be much
shorter than 2 h between the end of S phase and mitosis. The
data shown are for one of three experiments that gave similar
results.
The CHO cells collected by mitotic shakeoff are cells that
become detached from the plate in a 15-min window (47), and
these cells are in metaphase. SLBP is not present in these cells,
while cyclin A and cyclin B are still present at high levels (Fig.
1A, lane 1). These cells complete mitosis within 30 min after
plating, and the levels of the mitotic cyclins drop dramatically
(Fig. 1A, lane 2). In synchronous CHO cells selected by mitotic
shakeoff, SLBP levels are tightly regulated during the cell cycle,
while SLBP mRNA levels are relatively constant. SLBP syn-
thesis is activated at the level of translation in G1 phase, while
SLBP is degraded sometime between S phase and mitosis.
Regulation of SLBP in HeLa cells. It is not possible to
directly collect G2-M cells by mitotic selection because the cells
enter S phase over a 2-h period (3 to 5 h postmitosis) and
hence do not synchronously exit S phase and progress through
the short 2-h G2-M period asynchronously. To obtain a popu-
lation of synchronous cells from late S phase through mitosis,
we synchronized HeLa cells at the beginning of S phase by
using a double thymidine block. HeLa cells were chosen be-
cause they arrest efficiently and, more important, essentially
100% of the cells reenter the cell cycle and progress synchro-
nously through S phase and mitosis into G1. These arrested
HeLa cells are not appropriate for studying the changes that
occur as cells enter S phase because these cells have already
progressed to the G1/S border, resulting in the accumulation of
SLBP (Fig. 4A and Fig. 6B, lane 2). To obtain HeLa cells in
G1, we arrested the cells with thymidine, released them, and
then arrested them in mitosis with nocodazole. When these
cells are released, they progress through G1 to S phase.
After releasing the HeLa cells from the thymidine block, the
cells progress through S phase synchronously, as assessed by
flow cytometry (Fig. 6A). More than 95% of the cells progress
through S phase and enter G2 synchronously (Fig. 6A). The
cells arrested at the G1/S border with the double thymidine
block have accumulated high levels of SLBP (Fig. 6B, lane 2).
SLBP levels stay high throughout S phase, and as cells exited S
phase, SLBP protein levels dropped rapidly (Fig. 6B, lanes 6
and 7). The cells complete mitosis about 12 h after release, as
evidenced by the degradation of cyclin A as the cells enter
anaphase 10 to 12 h after release (Fig. 6B, lanes 9 and 10).
SLBP is degraded about 4 to 6 h prior to the degradation of
cyclin A. The 4N DNA content of the cells at 6 to 8 h after
release and the timing of SLBP degradation relative to cyclin A
degradation demonstrate that SLBP is degraded near the end
of S phase or early in G2.
The levels of SLBP mRNA did not change significantly when
cells were released from the thymidine block. In particular,
there were high levels of SLBP mRNA in late G2/M cells (Fig.
6C, lane 9) and in G1 cells which had just completed mitosis
(Fig. 6C, lane 10). By 12 h after release from the double
thymidine block, most of the cells are in G1 phase. The level of
SLBP protein is low in G1 cells (Fig. 6B, lanes 10 and 11), as
is histone mRNA (Fig. 6C, lane 10). The levels of SLBP
mRNA are relatively constant as the HeLa cells progress
through S and G2 into G1 phase (Fig. 6C), varying no more
than twofold. Thus, SLBP is regulated similarly in CHO cells
and HeLa cells, and most of the regulation is at the posttran-
scriptional level.
SLBP is degraded by the proteasome at the end of S phase.
The levels of histone mRNA increased rapidly after release
from the thymidine block and remained high as cells pro-
gressed through S phase and then declined dramatically (Fig.
6C), at about the same time as the levels of SLBP protein
dropped precipitously.
The degradation of SLBP at the end of S phase is prevented
by treatment with proteasome inhibitors. Cells were synchro-
FIG. 5. Half-life of SLBP in CHO cells. (A) Exponentially growing CHO
cells were labeled with [35S]methionine for 30 min. The cells were washed and
then chased with unlabeled medium, and cell extracts were prepared at the
indicated times. The cell extracts were treated with anti-SLBP, and the immuno-
precipitates were analyzed by SDS-polyacrylamide gel electrophoresis. The SLBP
band is indicated with an arrow, and its identity was confirmed by competition
with the antigenic peptide, as in Fig. 3B. (B) The data from exponentially grow-
ing cells (solid circles) and from S-phase cells (x’s), labeled and chased as de-
scribed for panel A, are plotted on a semilog plot to estimate the half-life of SLBP.
A0 is the intensity of SLBP at zero time, and A is the intensity of SLBP at the
indicated times.
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nized at the G1/S boundary by double thymidine block, re-
leased, and allowed to progress into S phase. At 4 h after
release, when cells are in mid- to late S phase, parallel plates of
cells were treated with either the proteasome inhibitor Mg132
or the inactive analog LLM or left untreated. Cells were har-
vested at 2-h intervals after treatment with the proteasome
inhibitor. The levels of SLBP increased in the cells treated with
the proteasome inhibitor (Fig. 7A, lanes 5, 8, and 11), suggest-
ing that SLBP is rapidly degraded by the proteasome as cells
enter G2 phase. In addition, the major form of SLBP which
accumulated in the presence of the proteasome inhibitor has a
lower electrophoretic mobility than the bulk of the SLBP
present at other phases of the cell cycle (Fig. 7A, lanes 5, 8, and
11). Treatment of these samples with calf intestinal phospha-
tase resulted in all the SLBP migrating as a single component
(Fig. 7B, lanes 2 and 4). This result demonstrates that a phos-
phorylated form of SLBP accumulates in the presence of a
proteasome inhibitor in late-S/G2 cells. It is possible that this
phosphorylated SLBP is the form that is rapidly targeted for
degradation by the proteasome. The rapid degradation of
SLBP occurs only at the end of S phase, since treatment of
asynchronous cells (not shown) or G1 cells (Fig. 3 and Fig. 8)
did not result in a significant increase in SLBP concentrations
or an increase in the amount of phosphorylated SLBP.
In exponentially growing cells and in synchronous cells pro-
gressing through the cell cycle, a small amount of SLBP with a
lower electrophoretic mobility is present. This form of SLBP is
a result of phosphorylation of SLBP. There are many potential
phosphorylation sites on SLBP (M. L. Whitfield, unpublished),
and different sites may be phosphorylated when SLBP accu-
mulates in S/G2 cells in the presence of proteasome inhibitors.
There were no consistent changes in the phosphorylation of
SLBP as detected by changes in electrophoretic mobility dur-
ing the cell cycle.
Translation of SLBP mRNA is regulated in HeLa cells dur-
ing G1. The HeLa cells arrested by double thymidine block at
the G1/S border have already accumulated SLBP. To obtain
HeLa cells which progress through G1 into S phase, cells were
synchronized by arrest at mitosis using nocodazole as de-
scribed in Materials and Methods. HeLa cells were released
from the mitotic block, and the SLBP levels were measured as
the cells progressed through G1 into S phase. The cells com-
plete mitosis 2 to 4 h after release from nocodazole and start
to enter S phase about 12 to 14 h after release from nocodazole
(Fig. 8A). As in the CHO cells, SLBP levels remained low
during G1 and increased as cells entered S phase (Fig. 8B,
lanes 1 to 7). We measured the levels of SLBP mRNA as cells
progress through G1 (Fig. 8C, lanes 1 to 5). The level of SLBP
mRNA was constant through late G1 and S phase. There was
a decrease in SLBP mRNA in cells arrested with nocodazole
(not shown). This is probably due to nocodazole’s holding the
cells in mitosis, which will greatly reduce the rate of transcrip-
tion. In addition, a proportion of the cells never progress after
being arrested with nocodazole, and these cells never adhere to
the plate. These cells were discarded 6 h after release.
Note that HeLa cells allowed to progress continuously
through mitosis did not show a decrease in SLBP mRNA (Fig.
6C, lanes 4 to 7), in agreement with the results obtained with
CHO cells (Fig. 2B). Thus, as in CHO cells, there are large
changes in SLBP protein levels as cells enter S phase, with very
little (less than twofold) change in SLBP mRNA levels, indi-
FIG. 6. SLBP levels in synchronized HeLa cells. HeLa cells were arrested at the beginning of S phase by a double thymidine block. Samples were taken from
arrested cells and from cells 30 min, 1 h, and 2 h after release and then at 2-h intervals. (A) Flow cytometry analysis of cells. The numbers of cells (arbitrary units) were
plotted against DNA content. (B) Whole-cell extracts were prepared in SDS loading buffer, and the proteins were resolved by SDS-polyacrylamide gel electrophoresis
and transferred to nitrocellulose. The blot was incubated with anti-SLBP, stripped, and then incubated with anti-cyclin A and finally with anti tubulin. The cell cycle
stage of each sample is shown above the lane. (C) Total-cell RNA prepared from cells every 2 h after release from the thymidine block (indicated above each lane)
was resolved by agarose gel electrophoresis, and the amounts of SLBP mRNA and histone mRNA were determined by Northern blotting as in Fig. 2.
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cating that SLBP is also regulated translationally or posttrans-
lationally in HeLa cells.
To determine if SLBP is degraded by the proteasome in G1
of thymidine-nocodazole-synchronized HeLa cells, we treated
G1 cells with Mg132 starting 6 h after release from nocodazole
and measured the levels of SLBP at 2-h intervals. Mg132 had
little effect on SLBP levels when G1 cells were treated (Fig. 8B,
lanes 10 and 11), in contrast to the results when late-S-phase
cells were treated (Fig. 7A). There was also no accumulation of
a slower-migrating form of SLBP in the G1-phase cells treated
with Mg132 (Fig. 8B, lanes 10 and 11). These results are
essentially identical to those found with CHO cells (Fig. 3A).
To demonstrate that translation of SLBP mRNA is regu-
lated during the progression from G1 to S phase, we analyzed
the distribution of SLBP mRNA on polyribosomes at different
stages of the cell cycle. Cytoplasmic lysates were prepared from
S-phase cells (4 h after release from the thymidine block) and
from G1 cells (either 12 h after release from the thymidine
block or 6 h after release from the nocodazole block). The
lysates were analyzed by sucrose gradient centrifugation, and
the distribution of total RNA, SLBP mRNA, and GAPDH
mRNA was determined in each sample. SLBP and GAPDH
are similar in size, and thus if the two mRNAs are translated
with similar efficiency, they should have a similar distribution
on polyribosomes. In the S-phase cells (Fig. 9A), the SLBP
mRNA was present near the bottom of the gradient with the
heavy polyribosomes. The GAPDH mRNA showed a similar
distribution, although there was some GAPDH mRNA higher
up in the gradient, suggesting that the SLBP mRNA is trans-
lated even more efficiently than GAPDH mRNA in the S-
phase cells (Fig. 9A). In contrast, in G1 cells, the SLBP mRNA
sedimented with smaller polyribosomes (estimated to be in the
di- to trisome range), while the GAPDH mRNA showed the
same distribution as in S-phase cells (Fig. 9B and C). Similar
results were found with G1 cells obtained 6 h after release from
nocodazole (Fig. 9B) or 12 h after release from the double
thymidine block (Fig. 9C). These results conclusively demon-
strate that SLBP mRNA is translationally regulated as cells
progress from G1 to S phase.
The results are summarized in Fig. 10, which shows the
changes in histone mRNA and SLBP protein levels during the
cell cycle. Like histone mRNA, SLBP is regulated by at least
FIG. 7. Effect of proteasome inhibitors on SLBP degradation in HeLa cells.
(A) HeLa cells were synchronized at the G1/S border by double thymidine block
and then released. Four hours after release of the cells, Mg132 was added to
some samples and LLM was added to others. Samples were taken at 2-h inter-
vals, and cell lysates were prepared and analyzed by Western blotting for SLBP.
The blots were stripped and analyzed for cyclin A and for tubulin. Lanes 5, 8, and
11 are samples from cells treated with Mg132 (M), and lanes 6, 9, and 12 are
samples from cells treated with LLM (L). (B) Extracts from the Mg132-treated
cells shown in lanes 8 (8M) and 11 (10M) of panel A were treated with calf
intestinal phosphatase (CIP) prior to analysis by Western blotting for SLBP.
FIG. 8. Regulation of SLBP during G1 in HeLa cells. HeLa cells were arrested in mitosis by blocking with thymidine followed by release and then blocking with
nocodazole as described in the text. Samples were harvested every 2 h after release, the cell cycle stage was determined by flow cytometry, and total-cell extracts or
total-cell RNA was prepared. Samples 8M and 10M (panel B, lanes 10 and 11; panel C, lanes 7 and 8) were prepared from cells which were treated with Mg132 starting
6 h after release from nocodazole and then harvested 2 and 4 h later, respectively. (A) Flow cytometric analysis of cells harvested at each time point. (B) Levels of SLBP
and tubulin measured by Western blotting after separation of equal amounts of total cell protein by SDS-polyacrylamide gel electrophoresis. (C) Levels of SLBP
mRNA, histone mRNA, and GAPDH mRNA measured by Northern blotting after separation of equal amounts of total-cell RNA by agarose gel electrophoresis.
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two different mechanisms during the cell cycle: by translation
as cells progress from G1 to S, and by rapid degradation of the
protein as cells progress from S phase into G2 (Fig. 10).
DISCUSSION
Histone mRNA levels increase and decrease rapidly about
35-fold during every cell cycle (18). To accomplish this dra-
matic regulation, histone gene expression is regulated at mul-
tiple steps (35, 49). Much of the regulation is posttranscrip-
tional and is mediated by the 39 end of histone mRNA. Since
SLBP is a component of the histone mRNP (17) and hence
must be present in stoichiometric amounts (1 molecule per
molecule of histone mRNA), accumulation of histone mRNA
without SLBP is not possible. It is likely that SLBP is a major
trans-acting factor that contributes to the cell cycle regulation
of histone mRNA. One major regulatory step is at the level of
formation of the 39 end of histone mRNA (18, 57). SLBP is
essential for this reaction in vitro (9, 10, 44) and in vivo (44).
Two possible mechanisms for regulating histone mRNA pro-
cessing have been proposed: regulation of a heat-labile factor,
which has not been well characterized, required for processing
(15, 31), and the blocking of the 59 end of U7 snRNA by a
negative regulator (21). Other laboratories have not observed
any alterations in U7 snRNP during the cell cycle (2). The low
levels of SLBP in G1 cells would certainly prevent accumula-
tion of cytoplasmic histone mRNA. The results reported here
suggest that regulation of the SLBP could account for the
posttranscriptional component of histone mRNA metabolism.
SLBP accumulates late in G1-phase and is present in both
HeLa and CHO cells arrested at the G1/S border. These cells
do not accumulate histone mRNA. It is possible that histone
pre-mRNA processing has been activated in these cells by the
accumulation of SLBP, but any histone mRNA formed would
be very unstable because DNA synthesis has been inhibited
(53). Alternatively, the cells arrested at the G1/S border might
be lacking another factor required for histone pre-mRNA pro-
cessing.
Although SLBP protein levels are regulated, the level of
SLBP mRNA is not regulated in continuously growing cells
(Fig. 2 and 6) or in serum-stimulated fibroblasts (M. L. Whit-
field and W. F. Marzluff, unpublished results). Similar results
were obtained for the SLBP mRNA in a study of global
changes in steady-state mRNA levels in serum-stimulated cells
using cDNA microarrays by Brown and coworkers (23). SLBP
mRNA is readily detectable in all adult tissues (33), suggesting
that the synthesis of SLBP protein is also regulated posttran-
FIG. 9. SLBP mRNA is translationally regulated during G1 phase. HeLa
cells were synchronized either by double thymidine block (A and C) or by
thymidine-nocodazole block (B), and cytoplasmic lysates were prepared 4 h after
release (S phase, panel A), 6 h after release from a thymidine-nocodazole block
(G1 phase, panel B), or 12 h after release from a double thymidine block (G1
phase, panel C). The cell cycle position was confirmed by flow cytometry. The
lysates were fractionated on 15 to 40% sucrose gradients, and RNA was prepared
from each fraction. The RNA was resolved by agarose gel electrophoresis and
detected by staining with ethidium bromide (top panels in each group). The
RNA was transferred to nylon and probed for either SLBP mRNA (middle
panels) or GAPDH mRNA (bottom panels).
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scriptionally in normal somatic cells. Since regulation of SLBP
is at the level of translation of preformed SLBP mRNA, SLBP
concentrations increase rapidly once the signal to initiate
SLBP synthesis is generated. The rapid synthesis of SLBP in
late G1 results in a large amount of free, active SLBP which
accumulates just prior to the maximal accumulation of histone
mRNA (cf. Fig. 1A and C, lanes 4). Synthesis and export of
histone mRNA from the nucleus is very rapid (48), suggesting
that activation of SLBP mRNA translation would result in very
rapid accumulation of cytoplasmic histone mRNA. Accumula-
tion of SLBP occurs late in G1, after induction of cyclin E
(unpublished results), and translation of SLBP mRNA may be
activated by the same signals that ultimately result in entry into
S phase.
Regulation of translation of selective mRNAs is probably
critical for progression from G1 to S phase. Overexpression of
eIF4E, one of the limiting factors for translation, results in
transformation of cells (30), and one of the targets of this
response is likely to be cyclin D mRNA (45). Activation of
translation through activation of the Tor kinase, which results
in phosphorylation of inhibitors of eIF4E, is an essential com-
ponent of progression from G1 to S phase (29). Thus, transla-
tional regulation of key proteins required for cell cycle pro-
gression may be a common theme in cell cycle regulation.
At the end of S phase there is a rapid degradation of histone
mRNA (13). The stem-loop at the 39 end of the histone mRNA
and presumably the bound SLBP are necessary for the change
in histone mRNA half-life (42). Since SLBP levels remain
constant when cells are treated with inhibitors of DNA repli-
cation (M. L. Whitfield and W. F. Marzluff, unpublished re-
sults) and histone mRNA is rapidly degraded (53), degradation
of SLBP is not required for the degradation of histone mRNA.
This result suggests that the degradation of SLBP is the result
of a cell cycle signal generated at the end of S phase, while the
degradation of histone mRNA occurs in response to cessation
of DNA replication, either as a result of inhibition or at com-
pletion of S phase.
Other critical cell cycle transitions are driven by the rapid
degradation of regulatory proteins (22, 27). During mitosis, the
anaphase-promoting complex (APC) is activated, resulting in
the degradation of cyclins A and B (20) as well as Pds1 (6) and
probably other proteins necessary for mitosis. The APC rec-
ognizes a specific sequence, termed the destruction box, and
directs ubiquitination and degradation of this set of proteins.
The APC is activated in mitosis and remains active during the
subsequent G1 phase (4). As cells progress from G1 to S phase,
there is degradation of the Cdk inhibitor, p27, in mammalian
cells (41) and degradation of Sic1 in yeast cells by a multipro-
tein complex termed the SCF (1, 12, 54, 58). The SCF is a
multiprotein complex containing Skp-1, cullin/Cdc53, and a
member of a diverse group of proteins containing an F-box
motif. The F-box is a 30-amino-acid motif present in diverse
proteins which interacts with Skp-1 and helps recruit phos-
phorylated substrates for ubiquitination (1, 12, 54, 58).
Subsequent purification and cloning of the subunits of the
APC complex identified a subunit, APC-2, which has homology
with the cullins (62, 64). Recently it was discovered that the
APC and SCF contain an additional conserved subunit. APC11
(64) has considerable homology with ROC/Rbx1/HRT1 (26,
40, 51), a subunit of the SCF complex. The cullins represent a
multigene family containing at least six members in mamma-
lian cells (28), and there are at least two distinct roc genes (40),
which may constitute a series of distinct ubiquitin ligase com-
plexes (Y. Xiong, personal communication). These findings
suggest that a conserved core is shared by different E3 ligases
that are involved in regulation of diverse cellular processes
(63). Many proteins are targeted for degradation during the
G1-to-S transition by a regulatory phosphorylation (8, 52, 59).
It is possible that other ubiquitin ligase complexes also regulate
degradation of a set of proteins at the S-G2 transition and that
SLBP might be one of the substrates targeted for degradation
at this time.
There are distinct differences between the regulation of
SLBP and the regulation of histone mRNA. SLBP accumulates
in late G1, and there are high levels of SLBP in late G1 cells
which contain little histone mRNA. Similarly, histone mRNA
is rapidly degraded when DNA replication is inhibited, but
SLBP is not degraded during this time. It is possible that
processing of histone mRNA is activated in cells blocked at the
G1/S border but the histone mRNA is very unstable (as it is in
S-phase cells in which DNA synthesis is blocked). Clearly the
signals regulating histone mRNA accumulation and SLBP ac-
cumulation are distinct. Histone mRNA levels are directly
coupled to DNA replication, while SLBP is probably regulated
by cell cycle signals which occur independently of DNA repli-
cation.
However, SLBP must be synthesized each cell cycle to allow
accumulation of histone mRNA. The regulation of SLBP ac-
cumulation is determined by a cell cycle signal that results in an
increased rate of translation of SLBP mRNA as cells progress
from G1 to S phase (Fig. 3). SLBP is then degraded near the
S-G2 border, as a result of a second cell cycle signal, making
new synthesis of SLBP necessary for the next round of histone
mRNA synthesis (Fig. 1). Thus, as with histone mRNA, both
the biosynthesis and stability of SLBP are regulated during the
cell cycle. We are currently investigating the molecular mech-
anisms underlying these two regulatory events.
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signal regulating mouse histone H4 mRNA levels in a mammalian cell cycle
mutant and sequences controlling RNA 39 processing are both contained
within the same 80-bp fragment. EMBO J. 5:3297–3303.
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